Use of rituximab in pediatric patients with steroidresistant nephrotic syndrome. A single center study
Introduction: Steroids are the cornerstone of therapy for nephrotic syndrome (NS) with a remission rate as high as 90%. In patients who do not respond to them or are steroid dependent, other immunosuppressive drugs have been used. Although rituximab use in NS is off-label, many authors have publishe...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Universidad de Antioquia
2015-01-01
|
Series: | Iatreia |
Subjects: | |
Online Access: | http://aprendeenlinea.udea.edu.co/revistas/index.php/iatreia/article/view/16785 |